Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Elevance Health Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Healthcare PlansSector: Healthcare

Fair Value Summary

Current Price$351.90
5Y Range9,203.02 – 14,022.45
5Y Selected11,612.73
(-) Safety Margin48.78%
5Y Buy Price$5,948.04
Upside (to Buy Price)1,590.27%
10Y Range10,445.08 – 15,566.55
10Y Selected13,005.81
(-) Safety Margin48.78%
10Y Buy Price$6,661.58
Upside (to Buy Price)1,793.03%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9720
Revenue R2 (10Y)0.9559
Net Income R2 (5Y)0.4167
Net Income R2 (10Y)0.8900
EBITDA R2 (5Y)0.6695
EBITDA R2 (10Y)0.9037
FCF R2 (5Y)0.8711
FCF R2 (10Y)0.3474
Safety Score0.5122

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth12.54%11.59%10.64%9.69%8.75%7.80%6.85%5.90%4.95%4.00%
Revenue198,984.05222,050.58245,683.72269,500.58293,068.67315,916.52337,547.51357,456.19375,146.76390,152.63
EBITDA156,104.73174,200.63192,741.04211,425.57229,914.94247,839.28264,808.98280,427.52294,305.93306,078.17
D&A-2,003.40-2,235.63-2,473.57-2,713.37-2,950.65-3,180.69-3,398.47-3,598.91-3,777.02-3,928.11
EBIT154,101.33171,965.00190,267.46208,712.21226,964.29244,658.60261,410.51276,828.60290,528.90302,150.06
Pro forma Taxes-39,125.82-43,661.34-48,308.28-52,991.34-57,625.48-62,118.01-66,371.26-70,285.86-73,764.33-76,714.90
NOPAT114,975.52128,303.65141,959.18155,720.87169,338.81182,540.59195,039.25206,542.74216,764.58225,435.16
Capital Expenditures-1,648.95-1,840.09-2,035.94-2,233.30-2,428.61-2,617.94-2,797.20-2,962.18-3,108.78-3,233.13
NWC Investment3,828.893,983.004,080.834,112.564,069.603,945.243,735.113,437.723,054.712,591.13
(+) D&A2,003.402,235.632,473.572,713.372,950.653,180.693,398.473,598.913,777.023,928.11
Free Cash Flow119,158.85132,682.19146,477.65160,313.49173,930.45187,048.57199,375.64210,617.19220,487.53228,721.27
Diluted Shares Outstanding227,475,000.00227,475,000.00227,475,000.00227,475,000.00227,475,000.00227,475,000.00227,475,000.00227,475,000.00227,475,000.00227,475,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.451.452.463.464.465.466.467.468.46
Valuation Date1/17/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.48%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF118,125.76127,583.66129,103.21129,401.93128,685.48126,850.30123,934.56120,004.45115,151.82109,490.52
Raw: 2,692,432.24
1,907,173.91
Raw: 3,540,590.57
1,622,696.42

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value2,540,073.962,851,028.11
(-) Net Debt22,615.5022,615.50
Equity Value2,517,458.462,828,412.61
(/) Shares Out227.48227.48
Fair Value$11,066.97$12,433.95
(-) Safety Margin48.78%48.78%
Buy Price$5,668.50$6,368.67
Current Price$351.90$351.90
Upside (to Buy Price)1,510.83%1,709.80%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.98%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF118,018.03127,060.89127,406.39126,529.75124,686.32121,791.82117,911.56113,135.45107,574.54101,356.73
Raw: 2,184,354.88
1,492,370.50
Raw: 2,872,460.88
1,213,138.63

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value2,116,071.882,398,610.11
(-) Net Debt22,615.5022,615.50
Equity Value2,093,456.382,375,994.61
(/) Shares Out227.48227.48
Fair Value$9,203.02$10,445.08
(-) Safety Margin48.78%48.78%
Buy Price$4,713.79$5,349.97
Current Price$351.90$351.90
Upside (to Buy Price)1,239.52%1,420.31%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.98%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.890.830.760.710.650.600.560.52
PV UFCF118,234.59128,113.44130,838.56132,366.66132,851.52132,168.40130,324.98127,359.62123,340.10118,361.14
Raw: 3,498,208.28
2,569,968.11
Raw: 4,600,198.68
2,289,656.67

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value3,212,372.883,563,615.69
(-) Net Debt22,615.5022,615.50
Equity Value3,189,757.383,541,000.19
(/) Shares Out227.48227.48
Fair Value$14,022.45$15,566.55
(-) Safety Margin48.78%48.78%
Buy Price$7,182.30$7,973.19
Current Price$351.90$351.90
Upside (to Buy Price)1,941.01%2,165.75%

Reverse DCF: Market Implied Growth

Current Price$351.90
WACC Used9.1%
IMPLIED REVENUE GROWTH94.32%
Metric2027202820292030203120322033203420352036
Implied Revenue378,581.49735,673.681,429,588.532,778,029.775,398,371.0810,490,316.0720,385,173.5339,613,229.6776,977,905.65149,586,337.89
Constant Implied Growth94.32%94.32%94.32%94.32%94.32%94.32%94.32%94.32%94.32%94.32%
Implied Free Cash Flow37.8673.57142.96277.80539.841,049.032,038.523,961.327,697.7914,958.63
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF35.2259.38105.77188.40335.57597.711,064.641,896.313,377.696,016.28

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$302.0311.49%$420.1339.10%
20182018-12-31$262.6314.73%$228.54-12.98%
20172017-12-31$225.0115.10%$313.2339.21%
20162016-12-31$143.7712.55%$210.8646.66%
20152015-12-31$139.449.73%$254.6582.62%
20142014-12-31$125.677.13%$161.5328.53%
20132013-12-31$92.396.96%$125.5735.92%
20122012-12-31$60.929.01%$119.0495.40%
20112011-12-31$66.2511.57%$184.88179.06%
20102010-12-31$56.8613.65%$49.61-12.75%
20092009-12-31$58.2914.48%$145.37149.39%
20082008-12-31$42.1314.36%$102.64143.63%
20072007-12-31$87.7313.78%$172.2796.37%
20062006-12-31$78.6913.88%$159.06102.14%
20052005-12-31$79.7913.40%$127.8160.18%
20042004-12-31$57.5014.52%$107.0486.15%
20032003-12-31$37.5012.13%$88.40135.74%
20022002-12-31$31.4512.51%$89.48184.53%
20012001-12-31$24.7511.74%$66.66169.32%
20002000-12-31$20.4510.59%$-2.90-114.17%
19991999-12-31$20.45-0.37%$-2.53-112.38%
19981998-12-31$20.45-3.87%$-1.46-107.16%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$12,882.41
Median
$12,589.88
10th Percentile
$10,440.49
90th Percentile
$15,705.72

Fair Value Distribution

$8,522.71 - $9,586.87
21
$9,586.87 - $10,651.04
116
$10,651.04 - $11,715.20
197
$11,715.20 - $12,779.37
213
$12,779.37 - $13,843.53
169
$13,843.53 - $14,907.70
133
$14,907.70 - $15,971.87
63
$15,971.87 - $17,036.03
38
$17,036.03 - $18,100.20
26
$18,100.20 - $19,164.36
12
$19,164.36 - $20,228.53
5
$20,228.53 - $21,292.70
2
$21,292.70 - $22,356.86
1
$22,356.86 - $23,421.03
1
$23,421.03 - $24,485.19
1
$24,485.19 - $25,549.36
0
$25,549.36 - $26,613.52
0
$26,613.52 - $27,677.69
0
$27,677.69 - $28,741.86
0
$28,741.86 - $29,806.02
1